GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE316nnn/GSE316636/primaryOK200TranscriptomicsHomo sapiensExpression profiling by high throughput sequencinghttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316636GEOGSEfalseMorusin induces GSDME-dependent pyroptosis in non-small cell lung cancer via the angiotensin II receptor type 2Lung cancer remains the leading cause of cancer-related mortality worldwide, its 5-year survival rate continues to be unsatisfactory. Current therapies are often limited by resistance, toxicity, or poor efficacy, highlighting the urgent need for novel strategies. Here, we performed a high-throughput screen for compounds and identified that morusin could activate gasdermin E (GSDME), which is expressed in non-small-cell lung cancer. Using a genome-wide CRISPR/Cas9 screen, we identified AGTR2 as a critical regulator of morusin-induced pyroptosis, which acts via activation of the caspase-3–GSDME signaling cascade. In mouse tumor models, pyroptosis induced by morusin suppresses tumor growth without cause weight loss. Thus, our study uncovers a novel mechanism through which morusin exerts its anti-tumor effect, thereby establishing AGTR2 as a potential therapeutic target and providing a rationale for pyroptosis-based non-small-cell lung cancer therapy.2026/08/31GSE316636GSM9457250GSM9457248GSM9457249GSM9457251GSM9457252GSM945725324676316636Homo sapiens